Novobind Livestock Therapeutics Inc.

Canada

Back to Profile

1-20 of 20 for Novobind Livestock Therapeutics Inc. Sort by
Query
Aggregations
Jurisdiction
        United States 8
        World 8
        Canada 4
Date
New (last 4 weeks) 1
2025 January (MTD) 1
2024 December 1
2025 (YTD) 1
2024 2
See more
IPC Class
C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria 14
C12N 15/13 - Immunoglobulins 11
C12P 21/08 - Monoclonal antibodies 9
A61P 31/04 - Antibacterial agents 8
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies 7
See more
Status
Pending 10
Registered / In Force 10
Found results for  patents

1.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Application Number 18777457
Status Pending
Filing Date 2024-07-18
First Publication Date 2025-01-09
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip
  • Cheung, Tsz Ying Silvia

Abstract

Described are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61P 31/04 - Antibacterial agents

2.

ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF

      
Application Number 18599359
Status Pending
Filing Date 2024-03-08
First Publication Date 2024-12-05
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor Abnousi, Hamlet

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 20/195 - Antibiotics
  • A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
  • A23L 33/18 - Peptides; Protein hydrolysates
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies
  • A61P 31/04 - Antibacterial agents

3.

ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF

      
Application Number CA2023051462
Publication Number 2024/092360
Status In Force
Filing Date 2023-11-02
Publication Date 2024-05-10
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.

IPC Classes  ?

  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
  • A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
  • A61K 31/12 - Ketones
  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
  • C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies

4.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF PLANTS AND USES THEREOF

      
Application Number CA2023050279
Publication Number 2023/205876
Status In Force
Filing Date 2023-03-03
Publication Date 2023-11-02
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Cheung, Tsz Ying Sylvia
  • Tupin, Audrey

Abstract

The present technology generally relates to methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in a plant.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A01N 63/50 - Isolated enzymes; Isolated proteins
  • A01P 1/00 - Disinfectants; Antimicrobial compounds or mixtures thereof
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12N 15/13 - Immunoglobulins
  • C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12P 21/08 - Monoclonal antibodies

5.

ANTIBODIES AGAINST DISEASE-CAUSING AGENTS APPLIED TO PLANT VASCULAR SYSTEMS

      
Application Number US2023063611
Publication Number 2023/168357
Status In Force
Filing Date 2023-03-02
Publication Date 2023-09-07
Owner
  • NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
  • INVAIO SCIENCES, INC. (USA)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Cheung, Tsz Ying Sylvia
  • Slovic, Avram Michael
  • Sheahan, Anjali Viswa
  • Ursin, Virginia Marie
  • Malvar Jr., Thomas Michael

Abstract

Provided herein are methods and systems useful for providing an antibody to a vascular plant, including effecting binding of an exogenous antibody to its corresponding antigen in a vascular plant. The methods and systems include introducing at least one exogenous antibody, such as at least one exogenous nanobody, into a plant's vascular system (e.g., into xylem or phloem or both).

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A01G 7/06 - Treatment of growing trees or plants, e.g. for preventing decay of wood, for tingeing flowers or wood, for prolonging the life of plants
  • A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
  • A61P 31/04 - Antibacterial agents

6.

Antibodies against microorganisms and uses thereof

      
Application Number 17409559
Grant Number 11939371
Status In Force
Filing Date 2021-08-23
First Publication Date 2022-08-18
Grant Date 2024-03-26
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor Abnousi, Hamlet

Abstract

HH fragments for reducing a bacterial population in domestic animals or humans.

IPC Classes  ?

  • A61K 39/02 - Bacterial antigens
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 20/195 - Antibiotics
  • A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
  • A23L 33/18 - Peptides; Protein hydrolysates
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61P 31/04 - Antibacterial agents
  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

7.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Application Number 17528783
Status Pending
Filing Date 2021-11-17
First Publication Date 2022-08-04
Owner Novobind Livestock Therapeutics, Inc. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a parasite population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a parasite population in an animal.

IPC Classes  ?

  • C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa

8.

ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF

      
Application Number 15734939
Status Pending
Filing Date 2019-06-04
First Publication Date 2022-04-21
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses

9.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF

      
Application Number 17292160
Status Pending
Filing Date 2019-11-12
First Publication Date 2022-03-03
Owner Novobind Livestock Therapeutics, Inc. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.

IPC Classes  ?

10.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Application Number 17141052
Status Pending
Filing Date 2021-01-04
First Publication Date 2021-09-02
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip
  • Cheung, Tsz Ying Silvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria

11.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Document Number 03140739
Status Pending
Filing Date 2020-05-19
Open to Public Date 2020-11-26
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a parasite population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a parasite population in an animal.

IPC Classes  ?

  • C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • A61P 33/00 - Antiparasitic agents
  • A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies

12.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Application Number IB2020000380
Publication Number 2020/234642
Status In Force
Filing Date 2020-05-19
Publication Date 2020-11-26
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade
  • Van Petegem, Filip
  • Cheung, Tsz, Ying Sylvia

Abstract

HHH fragments for reducing a parasite population in an animal.

IPC Classes  ?

  • C07K 16/20 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
  • A61K 39/395 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
  • A61P 33/00 - Antiparasitic agents
  • A61P 33/02 - Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/18 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies

13.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF

      
Document Number 03118819
Status Pending
Filing Date 2019-11-12
Open to Public Date 2020-05-22
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.

IPC Classes  ?

  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
  • A61P 31/12 - Antivirals
  • C07K 14/015 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies

14.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF CANINES AND FELINES AND USES THEREOF

      
Application Number IB2019001196
Publication Number 2020/099922
Status In Force
Filing Date 2019-11-12
Publication Date 2020-05-22
Owner NOVOBIND LIVESTOCK THERAPEUTICS, INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade, Andrew
  • Van Petegem, Filip
  • Cheung, Tsz, Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a viral population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a viral population in an animal.

IPC Classes  ?

  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
  • A61P 31/12 - Antivirals
  • C07K 14/015 - Parvoviridae, e.g. feline panleukopenia virus, human parvovirus
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies

15.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Document Number 03103656
Status Pending
Filing Date 2019-07-03
Open to Public Date 2020-02-20
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip Louis Arsene
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
  • A61P 31/04 - Antibacterial agents
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
  • C12N 15/13 - Immunoglobulins
  • C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12P 21/08 - Monoclonal antibodies

16.

ANTIBODIES AGAINST DISEASE CAUSING AGENTS OF POULTRY AND USES THEREOF

      
Application Number IB2019001198
Publication Number 2020/035741
Status In Force
Filing Date 2019-07-03
Publication Date 2020-02-20
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade, Andrew
  • Van Petegem, Filip Louis Arsene
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in an animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in an animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
  • A61P 31/04 - Antibacterial agents
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
  • C12N 15/13 - Immunoglobulins
  • C12N 15/63 - Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12P 21/08 - Monoclonal antibodies

17.

ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF

      
Document Number 03102039
Status Pending
Filing Date 2019-06-04
Open to Public Date 2020-01-09
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade Andrew
  • Van Petegem, Filip Louis Arsene
  • Cheung, Tsz Ying Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
  • A61P 31/12 - Antivirals
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
  • C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
  • C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
  • C12N 15/13 - Immunoglobulins
  • C12P 21/00 - Preparation of peptides or proteins
  • C40B 40/08 - Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries

18.

ANTIBODIES AGAINST AQUACULTURE DISEASE-CAUSING AGENTS AND USES THEREOF

      
Application Number IB2019000687
Publication Number 2020/008254
Status In Force
Filing Date 2019-06-04
Publication Date 2020-01-09
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor
  • Abnousi, Hamlet
  • Loutet, Slade, Andrew
  • Van Petegem, Filip Louis, Arsene
  • Cheung, Tsz Ying, Sylvia

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial or viral population in an aquatic animal. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial or viral population in an aquatic animal.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A61K 39/42 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
  • A61P 31/12 - Antivirals
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C07K 16/08 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from viruses
  • C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
  • C12N 1/21 - Bacteria; Culture media therefor modified by introduction of foreign genetic material
  • C12N 15/13 - Immunoglobulins
  • C12P 21/00 - Preparation of peptides or proteins
  • C40B 40/08 - Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries

19.

Antibodies against microorganisms and uses thereof

      
Application Number 16300457
Grant Number 11130800
Status In Force
Filing Date 2017-05-19
First Publication Date 2019-07-04
Grant Date 2021-09-28
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor Abnousi, Hamlet

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.

IPC Classes  ?

  • A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 20/195 - Antibiotics
  • A23L 33/18 - Peptides; Protein hydrolysates
  • A23K 50/75 - Feeding-stuffs specially adapted for particular animals for birds for poultry
  • A61P 31/04 - Antibacterial agents
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 39/00 - Medicinal preparations containing antigens or antibodies

20.

ANTIBODIES AGAINST MICROORGANISMS AND USES THEREOF

      
Application Number IB2017000684
Publication Number 2017/199094
Status In Force
Filing Date 2017-05-19
Publication Date 2017-11-23
Owner NOVOBIND LIVESTOCK THERAPEUTICS INC. (Canada)
Inventor Abnousi, Hamlet

Abstract

Described herein are methods and antibodies useful for reducing, eliminating, or preventing infection with a bacterial population in domestic animals or humans. Also described herein are antigens useful for targeting by heavy chain antibodies and VHH fragments for reducing a bacterial population in domestic animals or humans.

IPC Classes  ?

  • C07K 16/12 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from bacteria
  • A23K 20/147 - Polymeric derivatives, e.g. peptides or proteins
  • A23K 20/195 - Antibiotics
  • A61K 39/40 - Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
  • A61P 31/04 - Antibacterial agents
  • C12N 1/19 - Yeasts; Culture media therefor modified by introduction of foreign genetic material
  • C12N 15/13 - Immunoglobulins
  • C12P 21/08 - Monoclonal antibodies